Alana Brennan
Profiles

Alana T Brennan, PhD

Associate Professor , Global Health - Boston University School of Public Health

617-358-2407
abrennan@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Alana Brennan, PhD, MPH, is an Associate Professor in the Department of Global Health at Boston University School of Public Health, with a secondary appointment in Epidemiology. She received both her MPH and PhD in Epidemiology from Boston University. Her research focuses on the epidemiology and prevention of diabetes and cardiometabolic disease, examining how clinical, social, and environmental factors shape disease progression and health outcomes. Her NIH- and American Heart Association-funded research spans diabetes care and treatment outcomes, cardiometabolic complications among people living with HIV, and environmental influences on cardiometabolic health in South Africa and the United States. She also studies Food Is Medicine interventions to address food insecurity and improve cardiometabolic health in underserved populations. Her research is expanding to examine diabetes heterogeneity—including subtypes and longitudinal disease trajectories—and its implications for Alzheimer’s disease and related dementias (AD/ADRD).

Other Positions

  • Associate Professor, Epidemiology - Boston University School of Public Health

Education

  • Boston University School of Public Health, PhD Field of Study: Epidemiology
  • Boston University School of Public Health, MPH Field of Study: Epidemiology
  • Knox College, BS Field of Study: Biology

Websites

Classes Taught

  • SPHEP755

Publications

  • Published on 9/11/2026

    Gumede SB, Manne-Goehler J, Kelechi Oladimeji E, Bulled N, Brennan AT, Lalla-Edward ST. The longitudinal care cascade for hypertension in people with and without HIV in South Africa: A clinic-based observational study. PLoS Med. 2026 Sep; 23(9):e1004957. PMID: 42726776.

     Read At: PubMed
  • Published on 9/1/2026

    Pederson AM, Buto P, Zimmerman SC, Velez M, Sims KD, Murchland AR, Wang J, Glymour MM, Spartano NL, Weuve J, Gilsanz P, Chi F, Whitmer RA, Brennan AT. Clinical modifiers of the association between type 1 diabetes and dementia incidence. Alzheimers Dement. 2026 Sep; 22(9):e71799. PMID: 42764447.

     Read At: PubMed
  • Published on 7/2/2026

    LaMattina KC, Zhou Y, Lauer DA, Brennan AT, Minkus CL. Trends in pediatric uveitis: A systematic review and meta-epidemiological investigation of geographic, economic, and climate factors. Surv Ophthalmol. 2026 Jul 02. PMID: 42392272.

     Read At: PubMed
  • Published on 4/30/2026

    Zheng A, Murray EJ, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Pisa PT, Fox MP, Maskew M. One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials. Open Forum Infect Dis. 2026 May; 13(5):ofag151. PMID: 42078192.

     Read At: PubMed
  • Published on 3/27/2026

    Kileel EM, Malvestutto CD, Zanni MV, Davies-Smith E, Fichtenbaum CJ, Lake JE, Lo J, Aberg JA, Martinez E, Patel K, Bloomfield GS, Chu SM, Awwad A, Diggs MR, Lu AB, Bares SH, Berrner D, Smieja M, Okeke NL, Kumar P, João E, Currier JS, Lu MT, Fox MP, Brennan AT, Douglas PS, Grinspoon SK, Ribaudo HJ. Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE. Lancet HIV. 2026 May; 13(5):e306-e315. PMID: 41911941.

     Read At: PubMed
  • Published on 3/18/2026

    Pederson AM, Buto P, Zimmerman SC, Velez M, Sims KD, Murchland AR, Wang J, Brennan AT, Glymour MM, Weuve J. Type 1 Diabetes and Incident Dementia: An Analysis in the All of Us Cohort. Neurology. 2026 Apr 14; 106(7):e214805. PMID: 41849727.

     Read At: PubMed
  • Published on 3/10/2026

    Zheng A, Fox MP, Greener R, Kileel EM, Bor J, Venter WD, Pisa PT, Murray EJ, Brennan AT, Maskew M. Initiation of dolutegravir vs efavirenz on 12- and 24-month weight, body mass index, blood pressure, and incident hypertension: A target trial emulation. Ann Epidemiol. 2026 May; 117:110074. PMID: 41819297.

     Read At: PubMed
  • Published on 12/24/2025

    Kuhn L, Brennan AT. No cause for complacency regarding health of children who are HIV-exposed but uninfected. AIDS. 2026 Feb 01; 40(2):249-251. PMID: 41457985.

     Read At: PubMed
  • Published on 12/10/2025

    Sass N, Havrylenko H, Gerber F, Amstutz A, Rosen S, Brennan A, Maskew M, Koenig S, Dorvil N, Geng EH, Glass T, Ford NP, Labhardt ND, Schandelmaier S. Effect of same-day HIV treatment initiation (SDI) on 1-year outcomes in low- and middle-income countries: systematic review and meta-analysis of randomised trials. BMJ Glob Health. 2025 Dec 10; 10(12). PMID: 41371927.

     Read At: PubMed
  • Published on 12/1/2025

    Dzomba A, Shumba K, Nattey C, Lauren E, Brennan AT, McLoed W, Fox MP, Bor J, Onoya D. HIV Patient Treatment Adherence Trajectories in First 24 months After ART Initiation Among Adults: An Electronic Health Records Cohort From South Africa. J Acquir Immune Defic Syndr. 2025 Dec 01; 100(4):305-314. PMID: 40778758.

     Read At: PubMed

View 86 more publications:View Full Profile at BUMC

News & In the Media

View all profiles